Company Profile
Spectrum Pharmaceuticals, Inc. is a biotechnology company with fully integrated commercial and drug development operations, with a primary focus in hematology and oncology. It operates through one segment: acquiring, developing and commercializing prescription drug products. The company markets two oncology drugs Zevalin and Fusilev and the company also develops and delivers treatment for cancer. It seeks to leverage its extensive contacts in the pharmaceutical and scientific communities to identify potentially important drug candidates that require further clinical development. The company was founded in December 1987 and is Henderson, NV.
52 Week
Range
$17.05 / $7.00
50 / 200 Moving Average
$7.36 / $10.17YTD Change
-27.23%3 Month Change
-30.01%52 Week Change
-28.28%Number of Employees
193Coverage Start Date
09/25/2003Number of Rating Changes
3Exchange
NASD
11500 South Eastern Avenue
Henderson,
NV
89052-5576
(Map)
www.spectrumpharm.com
Listed: NASD
Rajesh C. Shrotriya, MD
69.6 Market Cap: 85,877.50M
24.2 Market Cap: 0.24M
- Community
